9:22 AM
Leo Group India
| ||
| Bristol's $5.3 Billion Amylin Deal Heralds Buying Hunger Bloomberg Bristol-Myers Squibb Co.'s $5.3 billion deal to buy diabetes drugmaker Amylin Pharmaceuticals Inc. (AMLN) gives Bristol (BMY) immediate access to a market of growing medical need, while heralding a burgeoning hunger among pharmaceutical companies ... See all stories on this topic » | ||
| Anand Sharma to review pharmaceutical sector tomorrow Economic Times Anand Sharma will hold discussions tomorrow with pharma players on ways to enhance shipments and promote 'Brand India' in world market. See all stories on this topic » | ||
| ||
| Ahead of the Bell: Amylin Pharma shares climb Businessweek Shares of Amylin Pharmaceuticals climbed before markets opened Monday, the first trading day after drugmaker Bristol-Myers Squibb Co. said it would buy the diabetes treatment developer. Bristol-Myers said Friday it would spend $5.3 billion in cash to ... See all stories on this topic » | ||
| KV Pharmaceutical: FDA Recommends Makena Over Compounded Drug ... Wall Street Journal The Food and Drug Administration issued further guidance on K-V Pharmaceutical Co.'s (KVA, KVB) Makena drug, recommending health-care providers prescribe the premature-birth drug for clinically-indicated patients rather than use compounded drug ... See all stories on this topic » | ||
| NPS Pharmaceuticals Announces Amended Royalty Agreement with Amgen MarketWatch (press release) NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) , a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has amended its license agreement with Amgen for royalties from ... See all stories on this topic » | ||
| ||
| Cubist Pharmaceuticals Announces Senior Executive Appointments MarketWatch (press release) LEXINGTON, Mass., Jul 02, 2012 (BUSINESS WIRE) -- Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that Robert J. Perez, currently Executive Vice President and Chief Operating Officer (COO), has been named President and COO, and ... See all stories on this topic » | ||
| Alexza Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare ... MarketWatch (press release) MOUNTAIN VIEW, Calif., July 2, 2012 /PRNewswire via COMTEX/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that the company will participate in the 7th Annual JMP Securities Healthcare Conference, being held in New York, New ... See all stories on this topic » | ||
| Avanir Pharmaceuticals Announces Notice Of Allowance Of US Patent ... MarketWatch (press release) U.S. Patent application number 13/415067, entitled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders," claims methods for treating pseudobulbar affect or emotional lability using ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment